Trial Information

Summary: Phase IV, Hormone Refractory Prostate Cancer Study

Clinical Trial to Compare approved medication along with placebo administered for 18 months to Men with Prostate Cancer who have failed First-Line Androgen Deprivation Therapy-(Assessed by rising PSA)

Patient Inclusion Criteria:

  • Men 40 to 85 years old
  • Prostate Cancer that has progressed during androgen deprivation therapy (rising PSA)

Patient Exclusion Criteria:

  • Prior Chemotherapy for prostate cancer

Contact:

Cheryl Ahlstrom, Recruitment Manager
South Florida Medical Research, Inc.
21150 Biscayne Blvd. #300
Aventura, FL 33180
Telephone: 305-931-8080 ext. 21
Fax: 305-931-8088
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:37:04 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA